GlassScriptPhysician profile
Harsh Amin
NPI 1942652193
$17,730.90
in general payments reported to CMS, 2019-2025
21 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $88.37 · 2021: $335 · 2022: $15K · 2023: $149 · 2024: $1,541 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,541 · Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,541.45 |
| Food and Beverage | $270.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $15,000.00 | 2022 | |
| Kerecis Limited | $1,696.24 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Linvatec Corporation | $261.30 | 2021-2022 | |
| Treace Medical Concepts, INC. | $197.37 | 2023-2025 | |
| Smith+Nephew, INC. | $112.60 | 2019-2022 | |
| Stryker Corporation | $72.74 | 2025 | Ortholoc 2 Lapifuse, Asnis |
| Nevro Corp. | $54.50 | 2022 | |
| Organogenesis INC. | $38.48 | 2020-2021 | |
| Wright Medical Technology, INC. | $36.92 | 2019 | |
| Zimmer Biomet Holdings, INC. | $35.18 | 2019 | |
| Depuy Synthes Sales INC. | $34.00 | 2021-2022 | |
| Integra Lifesciences Corporation | $31.24 | 2019 | |
| Biotissue Holdings INC. | $28.87 | 2021 | |
| Kci USA, INC. | $22.74 | 2019 | |
| Paratek Pharmaceuticals, INC. | $21.25 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $19.34 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.12 | 2019 | |
| Baudax Bio INC. | $16.35 | 2021 | |
| Bsn Medical INC | $12.35 | 2022 | |
| Horizon Therapeutics Plc | $11.91 | 2021 | |
| Acell, INC. | $10.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsh Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.